The fate of inspired mercury vapour (Hg 0 ) is critical in the central nervous system (CNS) where it can circumvent the blood-brain barrier (BBB) at the neuromuscular junction (NMJ) and accumulate indefinitely in motor neurons by retrograde transport. The detoxification of systemic Hg 0 by lung and liver requires investigation. We exposed 129/Sv wild-type (Wt) and 129/Sv MT-I, II double knockout (KO) mice to 500 µg Hg 0 /m 3 for 4 hours to investigate the expression of MT in the lung, liver, and spinal cord following Hg 0 exposure using unexposed groups as controls. There were congestive changes in liver and lung of both Wt and MT-KO groups of Hg 0 -treated mice; these changes appeared more pronounced in the MT-KO group. Motor neurons in the spinal cord did not show any pathological changes. Based on expression of MT, liver appears to have a major role in trapping and stabilising mercury. In the spinal cord, MT was expressed in all white matter astrocytes and in some grey matter astrocytes. Notably, motor neurons did not express MT, and the presence of MT could not be demonstrated in the axons of the ventral root. The absence of MT expression in motor neurons and their axons suggests the dependence of the motor system on the detoxifying capacity of liver MTs.
INTRODUCTION
MTs are a highly conserved low molecular weight polypeptide superfamily of cysteine-rich proteins that have a strong affinity for group Ib and IIb transitional metals (30) . Mammalian MTs can be subclassified into 2 ubiquitous isoforms, MT-I and MT-II, both of which have 2 domains that bind 7 equivalents of bivalent metal ions under normal conditions. An additional isoform, MT-III, is predominantly found in the CNS; although it binds heavy metals, induction of MT-III by them is not known to occur (23, 24) . MTs can limit the toxic effects of heavy metals on cells by binding and sequestering them (26, 29) .
In humans, Hg 0 is a significant toxicant in the occupational setting, and among the general population exposure commonly occurs as a result of continuous off-gassing from dental amalgam (1, 34, 41, 42) . Exposure to organic mercury is less widespread in humans and results in a different metabolism and pathology (17) .
The cellular distribution of MTs and their induction in tissue by mercury may determine the fate of this metal in other critical regions of the body by acting as traps or barriers to further dispersion. The metabolism of Hg 0 begins at the point of entry in the lungs. In humans approximately 80% of inhaled Hg 0 is absorbed by the lungs (31) , 20% of which is deposited in the lung parenchyma and 60% of which passes directly from the alveolar air to the blood (19) . Hg 0 is oxidised to the mercuric mercury (Hg 2+ ) by catalase ( Figure 1 ) in the blood (17) , liver (28) , and in neurons (40) . In the CNS, Hg 0 can readily cross the BBB; however, Hg 2+ is impermeable to it except at the NMJ. In the circulation Hg 2+ can travel to skeletal muscle and eventuate at the NMJ (Figure 1 ). Motor neurons accumulate Hg 2+ by transporting it from the NMJ to the cell body along the microtubular transport system by a process called retrograde transport (3) (4) (5) . The degree to which this process occurs may depend on the ability of the liver and lung to trap and stabilise Hg 2+ before it reaches the NMJ.
The significance of intraneuronal mercury deposits in motor neurons of the CNS remains controversial. Case reports of a link between human exposure to inorganic mercury and the onset of clinical symptoms that simulate motor neuron disease (MND) (2, 8, 10, 11, 20, 27, 32) are common in the literature. Furthermore, other reports have found significant levels of heavy metals with an antecedent clinical diagnosis of MND (12, 13, 36, 37) .
We examine the immunohistochemical expression of MT-I and MT-II in Wt mice to establish their distribution and induction in tissues, and thereby identify organs that reduce the dissemination of heavy metals in the body. Similarly, regions of particularly vulnerability to heavy metal exposure can thus also be identified by their lack of MT expression and or induction.
MATERIALS AND METHODS

Mouse Strains Used
MT-I and II double-KO mice were imported from Jackson Laboratory (Bar Harbor, Maine, USA) and bred in parallel with Wt 129/SvEms mice, which represent a genetically similar background to the double-KO mutant strain. The MT-deficient mice were engineered by deleting both MT-I and MT-II genes in one targeting event by homologous recombination (29) . One to 6 mice were housed in polycarbonate cages (model AS340, Able Scientific) post Vol. 31, No. 5, 2003 MT-EXPRESSION IN MICE RECEIVING MERCURY VAPOUR 515 FIGURE 1.-The fate of inhaled Hg 0 in experimental mice (A) begins with absorption into the lung parenchyma (B) and conversion to the divalent mercuric species Hg 2+ by red blood cell-associated catalase. In the circulatory system, conversion to Hg 2+ continues, and distribution to the liver (C) results in significant upregulation of hepatic MT · Hg 2+ has a higher affinity for MT binding sites (D) and readily replaces it from Zn-MT stores. The hepatic Zn 2+ levels (zinc pool) increase, resulting in increased transcription of apothionein (the precursor protein to MT). Further exposure to Hg 0 results in further displacement of Zn 2+ commencing with the alpha domain (4 binding sites) followed by the beta domain (3 binding sites). Unbound Hg 2+ is redistributed to skeletal muscle where it passes from capillaries and diffuses to the NMJ (E). Hg 2+ passes through the postsynaptic membrane and is carried to the cell body of the motor neuron along the axonal-microtubular transport system (F). It is stored in lysosomes in the motor neuron cell body. Astrocytes express MT in the CNS and are in direct communication with motor neurons and the BBB forming part of its structural integrity (G, F). Although bivalent metal cations such as Hg 2+ cannot cross the BBB, Hg 0 can, and, at high levels of exposure, can result in accumulation in the brain (G).
Hg 0 exposure, and given a commercial mouse food (Gordon's Stock Feed, Australia) and tap water ad libitum. Both strains were maintained in an air-conditioned animal holding room with a 12-hour light and 12-hour dark cycle at a temperature between 18-22 • C and a relative humidity between 40-60%. Food, water and paper bedding material (Fibre Cycle, Australia) were changed weekly, and mice were kept under observation on a daily basis. Ethics approval was obtained from the University of Sydney Animal Ethic Commit-tee for the breeding and Hg 0 exposure of both mutant and Wt strains.
Hg 0 -Exposure Method
The temperature of liquid mercury (50 ml) in the reaction chamber was raised to between 48-50 • C with a heat-belt (Robotemp 515, George Ulanet) and monitored with an electronic temperature probe (Mini Thermometer Quick Model 90350-20). Vaporisation of liquid mercury occurs at a rate R 516 STANKOVIC ET AL TOXICOLOGIC PATHOLOGY proportional to the fraction of mercury atoms having energy equal to, or greater than the escape energy E, from the surface according to the following relation.
This fraction is given by the Boltzmann factor e −E/K T where K is the Boltzmann constant, T is the absolute temperature (Kelvin), and C 1 is a constant of proportionality. The molar heat of vaporisation H vap for liquid mercury (the amount heat that must be added to one mole of liquid mercury at its boiling point to convert it to vapour) is expressed in the Clausius-Clapeyron equation:
where LnP is the natural log of the vapour-pressure, H vap = 59 KJ/mol for liquid mercury, and C is a constant of proportionality. Vapour dissipates into a reaction chamber according to Boltzmann's Law. The negative pressure created by an extraction fan at the terminal end of the exposure apparatus draws it into a mixing chamber where it is diluted with ambient air until a stable vapour flow of 500 µg Hg 0 /m 3 is achieved through the exposure chamber.
Vapour pressure through the exposure chamber, can be regulated by controlling the amount of heat applied to the liquid mercury (Clausius-Clapeyron equation), the proportion of air mixed with the vapour and the speed of the extraction fan.
Hg 0 -Exposure Apparatus The exposure apparatus ( Figure 2 ) is a closed system and is a modification of the Eide and Wesenberg Hg 0 exposure apparatus (15) consisting of four Perspex chambers that are connected to each other by concertina-type, polyvinyl chloride-reinforced ducting (Rubicon Industrial). Experimental animals are exposed to Hg 0 in the exposure chamber. Modified polycarbonate cages with substitute wirescreen floors are used to maintain the mice in the exposure chamber. The cages are held off the floor by 2 Perspex slats allowing unimpeded flow of Hg 0 through the cage to the mice during an exposure-session. The exhaust contains a series of charcoal filters that remove the Hg 0 before it passes through the ducting to a laboratory fume hood.
Detection of Hg 0 Levels
The Hg 0 pressure was monitored by sampling the air in the exposure chamber during the course of the total exposure with the use of a Hg 0 -analyser (Jerome 431-X; Arizona Instruments Corporation, Phoenix, Arizona). Vapour levels within the exposure chamber are detected by changes in the resistance of a gold film located in the analyser. The analyser is directly interfaced to an IMB-PC and printer where Hg 0 concentrations are graphed in real time with a computer program (Jerome Communications Interface Software, Arizona Instrument Corporation). The Hg 0 flow through the exposure chamber is expressed as an average, and is calculated by taking the sum of the sample values (measured by the mercury vapour-monitor at a predetermined periodicity, usually every 15 minutes) over the total number of sampling events:
where χ i, is the Hg 0 flow (µg Hg 0 /m 3 ) measured during a given sampling event i, and where N , is equal to the total number of sampling events that are taken over the entire exposure session. Total Hg 0 dose TMD (µg Hg 0 hr/m 3 ) is the average Hg 0 flow through the exposure chamber, multiplied by the length of time E t (hr) of the exposure, multiplied by the number of individual doses N d given:
Hg 0 -Exposure Animal Dosage Paired age, sex, and weight matched mice of both Wt and KO strains were given a single dose of Hg 0 for 4 hours at 500 µg Hg 0 /m 3 which equates to a total mercury dose TMD = 2,000 µg Hg 0 hr/m 3 . Control mice of both strains were never exposed to Hg 0 . All mice were maintained postexposure in unmodified polycarbonate cages in an animal holding facility.
Anaesthesia and Cardiac Perfusion of Mice
Mice were anaesthetised with 0.3 ml of Pentothal (active constituent Thiopentone Sodium, Rhone Merieux Australia) by intraperitoneal injection and were monitored for response to gentle stimulus by squeezing of the foot-paw. Surgical procedures were commenced after no sign of response to stimulus was detected. The thorax was opened and the right atrium severed by a small cut with a pair of microdissecting scissors (Hadland Photonics, INS300500). Deoxygenated blood was allowed to flow unimpeded out of the right atrium. The left ventricle (while still beating) was then immediately perforated with a 19-gauge needle and manually syringeperfused with 50 ml of 4% paraformaldehyde in 0.1M phosphate buffered saline (pH of 7.3) at room temperature (RT), at a flow rate of approximately 20 ml/min. No anticoagulants were used in the perfusion solution.
Dissection and Histological Preparation of the Spinal Cord, Liver, and Lung
All mice survived the single dose (TMD = 2000 µg Hg 0 hr/m 3 ) of Hg 0 up to and including the culling intervals at 24 hours, 48 hours, 5 days, 15 days, and 3 months post Hg 0exposure. The spinal cords were taken from all experimental groups and strains at all cull intervals. The liver and lung were taken from all experimental groups and strains after a 3-month time period.
The spinal cord was initially partially excised with a scalpel blade by first removing the skeletal muscle from around the dorsal surface of the vertebral column and then removing the dorsal lamellae to expose the spinal cord. The spinal cord, liver, and lungs were fixed in neutral buffered 10% formaldehyde in situ for 48 hours prior to dissection and blocking for routine histological processing to paraffin. Seven-micrometer thick serial transverse-sections of the cervical and thoracic regions of the spinal cord and 7-µm-thick serial sections of Vol. 31, No. 5, 2003 MT-EXPRESSION IN MICE RECEIVING MERCURY VAPOUR 517 FIGURE 2.-A mercury vapour-exposure apparatus is used to expose experimental mice. Liquid mercury is placed in the reaction chamber and is heated to 48-50 • C. Mercury is vaporised and extracted through a series of perspex chambers by a fan at the terminal end of the apparatus. Ambient air is mixed with Hg 0 through inlet holes diluting the vapour mixture to the desired level. Experimental mice are placed in the exposure chamber where the Hg 0 flow (measured in µgHg 0 /m 3 ) is monitored by a mercury vapour-analyser (Jerome 431-X, Arizona Instruments Corporation, USA). The mercury vapour-analyser is interfaced to an IBM PC-type computer and is plotted over time with Jerome Communications Interface Software (Arizona Instruments Corporation, USA). the liver and lung were acquired and placed on silane-coated slides (3-aminopropyl-triethoxy-silane, Sigma A-3648).
Immunohistochemical and Histochemical Staining Techniques
Paraffin sections of the lung, liver, and spinal cord from Wt and MT-KO, Hg 0 -exposed and control groups were taken to water and rinsed in 0.1M Tris-HCl buffer pH 7.6. Endogenous peroxidase was blocked with 3% H 2 O 2 in methanol, for 5 minutes at RT. Antigen retrieval in spinal cord sections was performed with 0.05% Pronase (bacterial protease XXIV, Sigma P8038) in phosphate buffered saline pH 7.6 for 1 minute at 37 • C. A second set of serial spinal cord sections were not treated with Pronase. Monoclonal mouse antibody E9 (DAKO-MT, Copenhagen Denmark, code M0639) raised against horse self-polymerised MT-I and MT-II, was used in combination with biotinylated-Fab anti-mouse IgG fragments (DAKO Animal Research Kit, Copenhagen Denmark, code K3954, K3955) to produce a primary-secondary antibody mixture. The addition of normal mouse immunoglobulins to this mixture absorbs excess biotinylated-Fab fragments that may bind to tissues nonspecifically. This final antibody mixture was then directly applied to the sections at a final 1:50 dilution of the primary antibody. Additional immunohistochemical staining was performed on spinal cord sections (serial to those used for E9 staining) using a 1:100 dilution of polyclonal rabbit anti-cow Glial Fibrillary Acidic Protein antibody (DAKO-GFAP, Copenhagen Denmark, code Z0334). Nonpronase-treated E9-sections were stained overnight at 3-4 • C while E9 sections treated with Pronase and GFAPsections were stained for 1 hour at RT. Goat anti-rabbit link antibody (Vector Laboratories, Burlingame CA, code BA-1000) was applied to the GFAP-sections at a 1:200 dilution for 30 min at RT. All sections were then incubated for 30 min at RT in avidin-biotin-peroxidase conjugate ABC kit, Vector Laboratories, Burlingame, CA. Peroxidase labelling was visualised by incubating sections in 0.03% H 2 O 2 /0.05% 3,3-diaminobenzidine tetrachloride (DAB, Sigma D5637) in 0.1M Tris-HCl buffer pH 7.6 for 5 minutes at RT. Rinsing in tap water stopped the reaction. Spinal cord sections were counterstained with 0.5% Cresyl Violet (CV) (Sigma C1893) for 3 minutes at RT, while Harris's Haematoxylin (5 minutes) was used for liver and lung.
Sections serial to those used for immunohistochemistry of liver and lung for all groups were stained with Harris's Haematoxylin for 5 minutes and Eosin, 1% alcoholic, for 3 minutes (H&E).
RESULTS
Immunohistochemical Expression of MT in Murine Lung Following Hg 0 Exposure
Macrophages are the only cells in the lung that appear to express MT. They are predominantly seen lining the bronchioles and clearly express cytoplasmic MT in Wt mice exposed to 500 µg Hg 0 /m 3 for 4 hours ( Figure 3F ). In haematoxylin and eosin (H&E) sections these macrophages did not appear to contain pigment such as carbon or haemosiderin. In addition to these findings, MT expression was not evident in lung macrophages of either mercury treated ( Figure 3H ) or control MT-KO mice ( Figure 3G ). Macrophages were also seen lining the bronchioles of control Wt mice; however, they appeared to be much less abundant and did not show the same levels of immunohistochemical expression for MT compared to Wt mice exposed to Hg 0 ( Figure 3E ). Macrophages are not a prominent feature in the parenchyma of Wt mice in either treated and control groups of mice.
Pathology of Murine Lung Following Hg 0 Exposure
Capillaries in the alveolar walls of Wt mice exposed to Hg 0 show marked areas of congestion compared to the Wt control group. These features were also evident in the lungs of the Hg 0 -treated MT-KO group compared to the MT-KO control group. 
Immunohistochemical Expression of MT in Murine Liver Following Hg 0 Exposure
Marked induction of MTs (arrow) was observed in the liver of Wt mice after exposure to Hg 0 ( Figure 3B ) compared to the basal levels of MT expression in Wt control mice ( Figure 3A) . Hepatocytes surrounding the central vein of the liver lobules lining sinusoids of the venous drainage (arrow) appear to show the most extensive expression for MT, and intranuclear staining commonly accompanied by increased nuclear ploidy ( Figure 3B , inset) was observed (arrow) in a significant number of hepatocytes. MT expression in the liver of Wt mice exposed to Hg 0 is evident 3 months postexposure. The liver of both MT-KO groups, Hg 0 -treated ( Figure 3D ) and control ( Figure 3C ) do not express MT and authenticate expression of MT in the Hg 0 -treated Wt group.
Pathology of Murine Liver Following Hg 0 Exposure
Liver of the Wt group exposed to Hg 0 appeared congested compared to liver of the Wt control group. Congestion was also prominent in the liver of the MT-KO mice exposed to Hg 0 and this group also showed areas of haemorrhage. The liver of the MT-KO control group did not appear congested. Incresed nuclear ploidy was observed in both strains that were exposed to Hg 0 suggesting a treatment-induced effect.
Immunohistochemical Expression of MT in Murine Spinal Cord Following Hg 0
Exposure to Hg 0 made no difference to the expression patterns of MT in the cells of the spinal cord in Wt mice. Moreover the expression patterns did not change over time. Expression of MT was most evident in the ependyma, substantia gelatinosa, and white matter ( Figure 4A ). In the white matter and ventral roots, expression was predominantly seen in astrocytes ( Figure 4C ) and Schwann cells surrounding myelinated axons ( Figure 4H ), respectively. Concurrent cytoplasmic and intranuclear expression was always observed in the white matter astrocytes. Sections pretreated with pronase digestion showed more definitive staining for MT (not shown), however pronase digestion did not reveal any further staining of structures that did not initially show immunoreactivity. In Wt mice, MT expression was also seen in a number of grey matter astrocytes ( Figure 4C) . In contrast to white matter astrocytes however, this staining was restricted to the nucleus ( Figure 4C , inset, arrow). Also these cells were less abundant and had larger nuclei compared to those that did not express MT in the grey matter ( Figure 4C Figure 4E ). Motor neurons did not express MT in either Wt control mice ( Figure 4C ) or in MT-KO control mice ( Figure 4E) , and exposure to Hg 0 showed no subsequent expression in these cells in either Wt ( Figure 4D ) (white arrow), or MT-KO ( Figure 4F ) strains. Axons in the ventral root of Wt mice did not stain for MT ( Figure 4H) .
Pathology of the Murine Spinal Cord Following Hg 0 Exposure
Histopathological assessment of motor neurons in the spinal cord of both Wt ( Figure 4D ) and MT-KO ( Figure 4F ) strains exposed to Hg 0 showed no obvious features of cellular degeneration on CV stains. Moreover, motor neurons did not show any morphological changes for up to 3 months.
Immunohistochemical Expression of GFAP in Murine Spinal Cord Following Hg 0 Exposure
Ventral roots of both Wt controls ( Figure 4G ) and MT-KO controls (not shown) showed positive staining for GFAP. Astrocytes of the white and grey matter of the spinal cord in both Wt ( Figure 4B ) and MT-KO strains (not shown) also showed positive staining for GFAP. The distribution of GFAP in astrocytes was found to be exclusively cytoplasmic in both strains and experimental groups.
DISCUSSION
The distribution of MTs in mammalian tissues and organs requires clearer definition, particularly in the cells of the CNS. The expression of MTs by neurons is still controversial, and this is thought to have arisen from variations in detection techniques and antibody specificity (18) .
Our study has accurately demonstrated the immunohistochemical expression of MT in Wt murine lung, liver and spinal cord. This was achieved with the combined use of a MT double-KO mutant murine strain that serves as a definitive negative control and, an immunohistochemical technique that utilises a serum-absorbed biotinylated primary-secondary antibody mixture. This technique permits the use of monoclonal antibody on murine tissue that would normally result in excessive nonspecific staining. To our knowledge, the expression of MTs in the murine spinal cord has not been previously investigated, probably due to the restrictions imposed by the use of mouse-derived monoclonal E9 antibody on mouse tissue.
In addition to establishing basal MT tissue distributions, we were able to show positive MT staining in Wt murine liver and pulmonary macrophages following Hg 0 exposure. We confirm previous work that claim a protective role afforded by MT in heavy metal exposure studies (21, 22, 26, 44) as demonstrated by an increased level of pathological change in the lung and liver of MT-KO mice following Hg 0 exposure. Furthermore, we have demonstrated pathological changes to Wt murine liver and lung, following exposure levels of Hg 0 (TMD = 2,000 µg/m 3 ) that approach the threshold limit values of acute exposure by the World Health Organisation (WHO). Acute pneumonitis has however been reported in cases of human exposure to more than 1,000-2,000 µg/m 3 (25, 38) .
Our study clearly demonstrates that, in the murine CNS, the motor system is particularly vulnerable to heavy metal exposure, emphasised by the lack of MT-immunoreactivity in motor neuron cell bodies and peripheral nerve motor axons in Wt mice. In MT-KO mice the motor system would appear to be at further risk of exposure to Hg 2+ (the oxidised metabolite of Hg 0 ) as the metal-anchoring capacity of the lung and liver would be severely compromised by the absence of MTs in these organs. The absence of MTs in motor neurons and peripheral motor axons is confounding as expression of MTs in axons would appear to serve as a strategic line of defence against further uptake of mercury and other heavy metal neurotoxicants. However our findings are supported by previous studies that demonstrate unimpeded retrograde uptake and accumulation of Hg 2+ by motor neurons (3, 5, 6, 39) .
Uptake of Hg 2+ into motor neurons occurs at the NMJ, since the rest of the CNS is protected by the BBB that is relatively impermeable to Hg 2+ (9) . Hg 2+ can pass from skeletal muscle to the NMJ where this line of defence can be bypassed. Previous studies have shown that mercury can persist in the cell body of the motor neuron for long periods of time where it is stored in lysosomes (14) . Intralysosomal Hg 2+ is not metabolised or excreted by the lysosome and can remain in the organelle indefinitely (4) . However the microtubular transport system is at particular risk to damage from mercury that can interfere with microtubule polymerisation. Divalent metals such as Hg 2+ are potent sulfhydryl blockers and have been found to completely inhibit tubulin polymerisation at concentrations of 10 mM (43) . Damage to the microtubular transport system of motor neurons would appear to be effected when Hg 2+ is transported en route from the NMJ to the cell body. Cumulative damage to the microtubular transport system over time may disrupt the efficient transport of essential growth factors to the motor neuron and this may be a trigger for apoptosis.
The expression of MT in astrocytes in this study confirms similar findings by other researchers (7, 23, 24) . Our results clearly demonstrate MT immunoreactivity in some grey matter astrocytes in murine spinal cord. Moreover MT expression is exclusively intranuclear in these cells and does not appear to change following exposure to Hg 0 . In contrast MT expression in white matter astrocytes is always seen in both the cytoplasmic and nuclear compartments. Astrocytes are believed to protect motor neurons from the deleterious effects of heavy metals (35) . White matter astrocytes would clearly not be in a position to afford this type of protection, as they are not located in the grey matter. Grey matter astrocytes would therefore appear to be the only subtype involved in this function. These specific neuroprotective mechanisms in the aforementioned cells are not well understood. In vitro studies have shown that MTs protect astrocytes against the oxidative affects of methylmercury in culture (7) ; however, inorganic mercury in this setting has yet to be investigated.
Our results have clearly established that murine motor neurons and their axons do not express MT. Despite these findings we found no pathological changes in the motor neurons of MT-KO mice that were exposed to Hg 0 . Further quantitative studies (that are beyond the scope of this work) will be required to determine the effects of Hg 2+ on motor neuron 522 STANKOVIC ET AL TOXICOLOGIC PATHOLOGY populations. Additional experiments involving repetitive low level (50 µg/m 3 ) exposure to Hg 0 over longer periods in this model are necessary to adequately assess the significance of the source from human dental amalgam. Deposits of Hg 2+ in motor neurons have been previously demonstrated in mice exposed to Hg 0 (33) . These intraneuronal deposits are a result of the retrograde transport of Hg 2+ from the NMJ. In MT-KO mice, the inability to express MTs in the liver and lung may result in increased redistribution of mercury to the NMJ and result in a greater uptake of mercury by motor neurons. This may result in increasing the passage of Hg 2+ through motor axons in this model and result in further interference with the microtubular transport system. A quantitative histochemical study of mercury deposits in motor neuron cell bodies would however be required to confirm this hypothesis.
Expression of MT in the lung is limited and it therefore does not appear to be a major line of defence against the initial systemic assimilation of Hg 0 . Immunoreactivity to MT is largely restricted to macrophages that are found lining the bronchioles.
The most significant response to Hg 0 by MTs is seen in the liver. After Hg 0 inhalation the liver of Wt mice show MT immunoreactivity in a large number of hepatocytes. Expression is predominantly cytoplasmic; however, some hepatocytes show intranuclear expression of MT. This is in direct contrast to the basal levels of MT in the Wt control strain that shows very little immunoreactivity. The results of this study suggest that liver MTs act as a primary defence against the systemic dissemination of Hg 2+ as shown by the extensive induction and expression of hepatic MTs, observed in response to Hg 0 exposure. We observed tenacious (up to 3 months postexposure) expression of liver MTs the significance of which has yet to be identified.
Increased axonal transport of Hg 2+ may occur following acute high-level mercury exposure or chronic low-level mercury exposure in association with a dysfunctional MT induction mechanism or transcription of dysfunctional mutated MT proteins.
In the general population humans are commonly exposed to Hg 0 released from stressed dental amalgam. The toxicological significance of this source of Hg 0 requires further investigation. The TMD over a human life span is difficult to accurately estimate and will vary from one individual to another. In addition to this, estimates of Hg 0 release rates are difficult to standardise and vary considerably from one study to another. For unstimulated dental amalgam, release rates of 7.4-3.3 ngHg 0 /min have been quoted and, for stimulated dental amalgam, release rates of 163.2-21.9 ngHg 0 /min have been quoted (1, 34, 41, 42) . These levels appear insufficient to cause concern to the motor system, however dental amalgam is typically a permanent fixture and release would therefore persist for very long periods. In individuals with compromised or defective heavy metal defence strategies, this may become significant predisposing factor to motor dysfunction.
